Kinvard Bio
PrivateLast Round
Grant
Jul 29, 2025
Total Funding Raised
$2.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kinvard Bio is a drug discovery company developing antibiotics intended to combat multidrug-resistant bacterial infections. The company offers rational drug design and a proprietary synthetic chemistry platform to create a differentiated class of ribosome-targeting antibacterials, including oxepanoprolinamides, enabling clients to address the critical global health threat of antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinvard Bio Comparables
Compare Kinvard Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cūrza | 81% | |
| ArrePath | 78% | |
| VenatoRx Pharmaceuticals | 75% | |
Kinvard Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 29, 2025 | ||||
| Seed | Feb 24, 2025 |
Kinvard Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Kineticos Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 196% MoM.
- Apr 23, 2026
Monthly visitors increased 41% MoM.
Kinvard Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinvard Bio's valuation, stock price, and market status.